Saniona AB operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Saniona AB with three other
companies in this sector in Sweden:
SyntheticMR AB (publ)
sales of 48.30 million Swedish Kronor [US$5.02 million]
Bioinvent International AB
(38.55 million Swedish Kronor [US$4.00 million]
of which 100%
was Drug Development), and
(35.60 million Swedish Kronor [US$3.70 million]
Sales increased substantially in 2018:
Saniona AB reported sales of SEK 54.88 million (US$5.70 million)
December of 2018.
increase of 165.2%
versus 2017, when the company's sales were SEK 20.69 million.
Despite this increase, sales are still
below the level achieved in 2016, when Saniona AB
reported sales of SEK 74.92 million.